Skip to content
Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
Juni 2020

RARE CANCER AGENDA 2030 – Ten Recommendations from the EU Joint Action on Rare Cancers

Rare Cancers Europe, a collaborating partner of the recently completed EU Joint Action on Rare Cancers (JARC), is committed to take over the JARC legacy and to support the rare cancer community towards the effective implementation of the Joint Action’s overarching deliverable, namely the Rare Cancer Agenda 2030. In the next years RCE will continue this collaborative effort by spreading awareness of rare cancers across Europe, strengthening healthcare networking as well as advancing clinical and methodological research in the field of rare cancers.